Industry association · Greece · EU Transparency Register 684432824847-17
Counts here are a floor, never a total: they cover the 583 consultation files tracked so far (42,224 submissions, mostly 2025–26), so an organization's real filing history is larger, not smaller.
Among the 1365 trade and business associations on this site, they rank #936 by legislative files engaged — a count of participation, not a measure of influence.
Self-declared to the EU Transparency Register (snapshot 2 Sept 2026).
Self-declared to the EU Transparency Register (snapshot 2 Sept 2026); cost bands are floors, not audited totals. Reused under Commission Decision 2011/833/EU.
Track Hellenic in PolicySpeak: request access →
Work at Hellenic Association of Pharmaceutical Companies? so we know who speaks for it.
Hellenic Association of Pharmaceutical Companies filed 2 positions between 5 Jan 2021 and 8 Nov 2023, across 2 of the 583 legislative files tracked here, attaching a full position paper 1 time.
The reform of the EUs pharmaceutical sector is a milestone of the European Health Union and a credible step in our collective step to pave the way towards a healthier, more resilient, and more equal Europe.SFEE fully supports the challenges of enhancing the availability and acceptability of medicines, all fostering a competitive innovation environment in Europe.
Filed in Greek · English published by the European Commission
Hellenic Association of Pharmaceutical Companies (SFEE) members are committed to ensuring that unmet needs are addressed and that available treatments reach all European patients. Children and rare disease (RD) patients have greatly benefited from the progress achieved through the Paediatric & Orphan Regulations.
Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.
Put Hellenic Association of Pharmaceutical Companies next to another organization. Same files, same register facts, side by side. Compare →
Organizations that also filed on at least two of the same consultations. A shared interest in the same dossiers — not evidence of coordination, and we do not suggest any.
Showing 5 of 52.
Everything on this page comes from Hellenic Association of Pharmaceutical Companies’s own submissions to the European Commission — we have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.
Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.